Advertisement
Screener

TriSalus Life Sciences, Inc. (TLSI) ROE

TriSalus Life Sciences, Inc. (TLSI) ROE

  • 2026-06-30: ROE -430.72%.
  • 2026-03-31: ROE -213.27%.
  • 2025-12-31: ROE 115.85%.
  • 2025-09-30: ROE 148.11%.

Complete source-backed roe history.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-430.72%
2026-03-31-213.27%
2025-12-31115.85%
2025-09-30148.11%
2025-06-30160.48%
2025-03-3179.18%
2024-12-31116.03%
2024-09-30271.98%
2024-06-30216.13%
2024-03-31178.30%
2023-12-31219.33%
2023-09-30-557.95%
2023-06-3026.68%
2023-03-3125.81%
2022-12-3126.64%
2022-09-3014.13%
2022-06-308.08%
2022-03-311.99%
2021-12-31-3.68%

Annual ROE

DateROE
2025-12-31115.85%
2024-12-31116.03%
2023-12-31219.33%
2022-12-3126.64%
2021-12-31-3.68%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cytosorbents Corp (CTSO)United States$0.274B-1.29
Mobia Medical, Inc. (MOBI)United States$0.293B
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
Embecta Corp. (EMBC)United States$0.319B2.10
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
PRO DEX INC (PDEX)United States$0.234B13.64
Neuronetics, Inc. (STIM)United States$0.216B-3.25